Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States.
Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States.
J Clin Neurosci. 2021 Apr;86:1-5. doi: 10.1016/j.jocn.2020.12.031. Epub 2021 Jan 25.
The standard of care for idiopathic normal pressure hydrocephalus (iNPH) is placement of a ventriculoperitoneal (VP) shunt. However, VP shunts require intracranial intervention and are associated with notable postoperative complications, with some groups reporting complication rates for VP shunts ranging from 17 to 33%, along with failure rates up to 17.7%. Lumboperitoneal (LP) shunts are an alternative for cerebrospinal fluid diversion that do not require intracranial surgery, thus providing utility in patients where intracranial surgery is not possible or preferred. Here we retrospectively reviewed our 25 patients with LP horizontal-vertical (LP-HV) shunts placement for initial treatment for iNPH from 2014 to 2019. All patients had preoperative gait dysfunction, 16 (64%) had urinary incontinence, and 21 (84%) exhibited cognitive insufficiency. Two weeks post-shunt placement, 23/25 (92%) patients demonstrated improvement in gait, 11/16 (68%) had improvement in incontinence, and 14/21 (66%) had improvement cognitive insufficiency. At six months or greater follow up 13/20 (65%) had improvement in gait, 7/15 (47%) showed improvement in incontinence, and 11/15 (73%) demonstrated improvement in cognitive function. Six patients (24%) required at least one revision of the LP shunt. Shunt malfunctions resulted from CSF leak in one patient, shunt catheter migration in two patients, peritoneal catheter pain in one patient, and clinical symptoms for overdrainage in two patients. Thus, we demonstrate that LP-HV shunt placement is safe and efficacious alternative to VP shunting for iNPH, resulting in notable symptomatic improvement and low risk of overdrainage, and may be considered for patients where cranial approaches should be avoided.
特发性正常压力脑积水(iNPH)的标准治疗方法是放置脑室-腹腔(VP)分流管。然而,VP 分流管需要进行颅内干预,并且与显著的术后并发症相关,一些研究小组报告的 VP 分流管并发症发生率为 17%至 33%,失败率高达 17.7%。腰腹腔(LP)分流管是一种替代脑脊液引流的方法,不需要进行颅内手术,因此对于那些不能或不希望进行颅内手术的患者具有实用性。在这里,我们回顾性分析了 2014 年至 2019 年期间,我们对 25 例 iNPH 初始治疗患者进行 LP 水平-垂直(LP-HV)分流管放置的病例。所有患者术前均存在步态功能障碍,16 例(64%)有尿失禁,21 例(84%)有认知功能障碍。分流管放置后两周,25 例患者中有 23 例(92%)步态改善,16 例尿失禁患者中有 11 例(68%)改善,21 例认知功能障碍患者中有 14 例(66%)改善。在 6 个月或更长时间的随访中,13 例(65%)步态改善,15 例尿失禁患者中有 7 例(47%)改善,15 例认知功能障碍患者中有 11 例(73%)改善。有 6 例(24%)患者需要至少一次 LP 分流管的修正。分流管故障的原因包括 1 例患者的脑脊液漏、2 例患者的分流管导管迁移、1 例患者的腹膜导管疼痛以及 2 例患者的过度引流临床症状。因此,我们证明 LP-HV 分流管放置是治疗 iNPH 的一种安全有效的 VP 分流管替代方法,可显著改善症状,且发生过度引流的风险低,对于那些应该避免颅内置入的患者可以考虑使用。